Hyperkalemia

Background

  • Serum potassium >5.0 mEq/L (some define >5.5 mEq/L)
  • Life-threatening when >6.5 mEq/L or with ECG changes
  • Most common electrolyte disorder causing cardiac arrest
  • Potassium homeostasis:
    • 98% intracellular (maintained by Na/K-ATPase)
    • Renal excretion is primary mechanism of potassium regulation

Causes

  • Decreased excretion (most common mechanism):
  • Transcellular shift (K moves out of cells):
    • Acidosis (metabolic acidosis shifts K extracellularly)
    • Insulin deficiency / DKA
    • Tissue destruction: rhabdomyolysis, tumor lysis, hemolysis, burns
    • Succinylcholine, beta-blockers, digitalis toxicity
    • Hyperkalemic periodic paralysis
  • Increased intake: excessive supplementation, salt substitutes (KCl)
  • Pseudohyperkalemia: hemolyzed sample, prolonged tourniquet, thrombocytosis, leukocytosis
    • Always repeat level if unexpected

Clinical Features

  • Often asymptomatic until severe
  • Muscle weakness, fatigue, paresthesias
  • Ascending paralysis (may mimic Guillain-Barre)
  • Cardiac dysrhythmias (most dangerous manifestation)
  • Nausea, vomiting, diarrhea

ECG Changes (Progressive)

  • Peaked T waves (earliest change, typically >5.5 mEq/L)[1]
  • Prolonged PR interval
  • Widened QRS
  • Loss of P waves
  • Sine wave pattern (pre-arrest)
  • Ventricular fibrillation / asystole
  • ECG changes do NOT reliably correlate with K level — some patients arrest without warning

Differential Diagnosis

Evaluation

  • Stat ECG (most urgent — look for peaked T's, widened QRS)
  • BMP: potassium level, creatinine (renal function), glucose, bicarbonate
  • Repeat K level if unexpected (rule out pseudohyperkalemia)
  • VBG/ABG (acidosis evaluation)
  • Digoxin level if on digoxin (hyperkalemia potentiates digitalis toxicity)
  • Urinalysis (myoglobinuria if rhabdomyolysis)
  • Consider: CK, uric acid, phosphorus (tumor lysis), cortisol (adrenal insufficiency)

Management

Step 1: Cardiac Membrane Stabilization

  • Calcium (does NOT lower K; protects myocardium from arrhythmia):
    • Calcium gluconate 10%: 10-20 mL IV over 2-3 minutes (preferred; less tissue necrosis if extravasates)
    • Calcium chloride 10%: 5-10 mL IV (via central line preferred; 3x more elemental calcium)
    • Onset: 1-3 minutes; duration 30-60 minutes; may repeat in 5-10 min if ECG unchanged
    • Give immediately if ECG changes present or K >6.5
  • Caution in digoxin toxicity: calcium may worsen toxicity → use cautiously or consider digibind first

Step 2: Shift Potassium Intracellularly

  • Insulin + Glucose (most reliable):[2]
    • Regular insulin 10 units IV + D50W 25g (50 mL) IV
    • Onset: 15-30 min; duration 4-6 hours; lowers K by 0.5-1.2 mEq/L
    • Monitor glucose q30min x 4h (hypoglycemia occurs in up to 20%)
    • Give D50 before or simultaneously with insulin
  • Albuterol (nebulized):
    • 10-20 mg nebulized (4-8x standard asthma dose)
    • Onset: 15-30 min; lowers K by 0.5-1.5 mEq/L
    • Additive with insulin; 40% of patients are non-responders
  • Sodium bicarbonate:
    • 50-100 mEq IV over 5-10 minutes
    • Minimal effect as monotherapy; useful in setting of severe metabolic acidosis
    • Do NOT rely on bicarb alone to lower potassium

Step 3: Remove Potassium from Body

  • Loop diuretics (furosemide 40-80 mg IV): if adequate renal function
  • Sodium polystyrene sulfonate (Kayexalate) 15-30g PO:
    • Delayed onset (hours); controversial efficacy; risk of bowel necrosis
    • Not recommended as acute treatment
  • Patiromer (Veltassa) or sodium zirconium cyclosilicate (Lokelma):
    • Newer potassium binders; better tolerated than Kayexalate
    • Lokelma 10g PO may lower K within 1 hour
  • Hemodialysis (most effective method of K removal):
    • Indicated for: refractory hyperkalemia, severe renal failure, K >7 despite medical therapy

Cardiac Arrest from Hyperkalemia

  • Standard ACLS + calcium 10-20 mL IV push
  • Insulin + glucose + bicarb + albuterol simultaneously
  • Avoid succinylcholine for intubation
  • Consider emergent dialysis

Disposition

  • Admit if K >6.0, ECG changes, renal failure, or ongoing cause
  • ICU if severe (>7.0), ECG changes, or refractory to treatment
  • Continuous telemetry for all admitted patients
  • Consider discharge if mild hyperkalemia (5.0-5.5), known chronic cause, normal ECG, correctable precipitant

See Also

References

  • Palmer BF. Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system. N Engl J Med. 2004;351(6):585-592. PMID 15295051
  • Weisberg LS. Management of severe hyperkalemia. Crit Care Med. 2008;36(12):3246-3251. PMID 18936701
  • Montford JR, Linas S. How dangerous is hyperkalemia? J Am Soc Nephrol. 2017;28(11):3155-3165. PMID 28778861
  • Long B, et al. An emergency medicine approach to hyperkalemia. Am J Emerg Med. 2018;36(5):918-921. PMID 29548654
  1. Montague BT, et al. Retrospective review of the frequency of ECG changes in hyperkalemia. Clin J Am Soc Nephrol. 2008;3(2):324-330. PMID 18235147
  2. Mahoney BA, et al. Emergency interventions for hyperkalaemia. Cochrane Database Syst Rev. 2005;(2):CD003235. PMID 15846652